Hmdb loader
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:51 UTC
Update Date2022-03-07 02:51:57 UTC
HMDB IDHMDB0015340
Secondary Accession Numbers
  • HMDB15340
Metabolite Identification
Common NameDezocine
DescriptionDezocine, also known as dezocinum or dalgan, belongs to the class of organic compounds known as tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane. Dezocine is a very strong basic compound (based on its pKa). In humans, dezocine is involved in dezocine action pathway.
Structure
Data?1582753286
Synonyms
ValueSource
(-)-13beta-Amino-5,6,7,8,9,10,11alpha,12-octahydro-5alpha-methyl-5,11-methanobenzocyclodecen-3-olChEBI
DezocinaChEBI
DezocinumChEBI
DalganKegg
(-)-13b-Amino-5,6,7,8,9,10,11a,12-octahydro-5a-methyl-5,11-methanobenzocyclodecen-3-olGenerator
(-)-13Β-amino-5,6,7,8,9,10,11α,12-octahydro-5α-methyl-5,11-methanobenzocyclodecen-3-olGenerator
(-5alpha, 11alpha,13S)-13-Amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecen-3-olHMDB
Dezocine hydrobromide, (5R-(5alpha,11alpha,13S*))-isomerHMDB
Dezocine hydrobromide, (5S-(5alpha,11alpha,13*))-isomerHMDB
Dezocine hydrobromide, (5alpha,11alpha,13*)-isomerHMDB
Dezocine hydrobromide, (5alpha,11alpha,13S*)-isomerHMDB
Dezocine, (5alpha,11alpha,13S*)-isomerHMDB
13-Amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-5,11-methanobenzocyclodecenolHMDB
5,11-Methanobenzocyclodecen-3-ol, 13-amino-5,6,7,8,9,10,11,12-octahydro-5-methyl-, (5alpha,11alpha,13S*)HMDB
Chemical FormulaC16H23NO
Average Molecular Weight245.3599
Monoisotopic Molecular Weight245.177964363
IUPAC Name(1R,9S,15S)-15-amino-1-methyltricyclo[7.5.1.0²,⁷]pentadeca-2,4,6-trien-4-ol
Traditional Namedezocina
CAS Registry Number53648-55-8
SMILES
[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N
InChI Identifier
InChI=1S/C16H23NO/c1-16-8-4-2-3-5-12(15(16)17)9-11-6-7-13(18)10-14(11)16/h6-7,10,12,15,18H,2-5,8-9,17H2,1H3/t12-,15-,16+/m0/s1
InChI KeyVTMVHDZWSFQSQP-VBNZEHGJSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane.
KingdomOrganic compounds
Super ClassBenzenoids
ClassTetralins
Sub ClassNot Available
Direct ParentTetralins
Alternative Parents
Substituents
  • Tetralin
  • 1-hydroxy-2-unsubstituted benzenoid
  • Aralkylamine
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Amine
  • Aromatic homopolycyclic compound
Molecular FrameworkAromatic homopolycyclic compounds
External Descriptors
Ontology
Not AvailableNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water Solubility0.014 g/LNot Available
LogP3.3Not Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.014 g/LALOGPS
logP3.77ALOGPS
logP3.23ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)10.43ChemAxon
pKa (Strongest Basic)9.67ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area46.25 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity74.19 m³·mol⁻¹ChemAxon
Polarizability28.49 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+159.22631661259
DarkChem[M-H]-156.25931661259
DeepCCS[M-2H]-194.1130932474
DeepCCS[M+Na]+169.22530932474
AllCCS[M+H]+160.832859911
AllCCS[M+H-H2O]+157.132859911
AllCCS[M+NH4]+164.232859911
AllCCS[M+Na]+165.232859911
AllCCS[M-H]-165.732859911
AllCCS[M+Na-2H]-165.732859911
AllCCS[M+HCOO]-165.932859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022.4.11 minutes32390414
Predicted by Siyang on May 30, 202211.2983 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20223.51 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid49.6 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid1621.3 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid253.5 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid158.8 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid165.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid215.9 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid446.2 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid402.8 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)272.9 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1014.4 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid382.8 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1002.5 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid267.5 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid309.2 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate336.9 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA243.2 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water53.8 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Dezocine[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N3490.4Standard polar33892256
Dezocine[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N2412.7Standard non polar33892256
Dezocine[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2N2298.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Dezocine,1TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N2258.5Semi standard non polar33892256
Dezocine,1TMS,isomer #2C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C31)[C@@H]2N[Si](C)(C)C2293.4Semi standard non polar33892256
Dezocine,2TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N[Si](C)(C)C2301.1Semi standard non polar33892256
Dezocine,2TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N[Si](C)(C)C2311.6Standard non polar33892256
Dezocine,2TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N[Si](C)(C)C2656.7Standard polar33892256
Dezocine,2TMS,isomer #2C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2382.4Semi standard non polar33892256
Dezocine,2TMS,isomer #2C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2505.8Standard non polar33892256
Dezocine,2TMS,isomer #2C[C@@]12CCCCC[C@@H](CC3=CC=C(O)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2773.8Standard polar33892256
Dezocine,3TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2446.0Semi standard non polar33892256
Dezocine,3TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2461.9Standard non polar33892256
Dezocine,3TMS,isomer #1C[C@@]12CCCCC[C@@H](CC3=CC=C(O[Si](C)(C)C)C=C31)[C@@H]2N([Si](C)(C)C)[Si](C)(C)C2601.6Standard polar33892256
Dezocine,1TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@@H]3CCCCC[C@](C)(C2=C1)[C@H]3N2555.3Semi standard non polar33892256
Dezocine,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)N[C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O)=CC=C1C22510.9Semi standard non polar33892256
Dezocine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1C22761.8Semi standard non polar33892256
Dezocine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1C22830.7Standard non polar33892256
Dezocine,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)N[C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O[Si](C)(C)C(C)(C)C)=CC=C1C22913.9Standard polar33892256
Dezocine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N([C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O)=CC=C1C2)[Si](C)(C)C(C)(C)C2815.4Semi standard non polar33892256
Dezocine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N([C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O)=CC=C1C2)[Si](C)(C)C(C)(C)C3019.2Standard non polar33892256
Dezocine,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)N([C@H]1[C@H]2CCCCC[C@]1(C)C1=CC(O)=CC=C1C2)[Si](C)(C)C(C)(C)C2968.1Standard polar33892256
Dezocine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@@H]3CCCCC[C@](C)(C2=C1)[C@H]3N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3121.9Semi standard non polar33892256
Dezocine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@@H]3CCCCC[C@](C)(C2=C1)[C@H]3N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C3152.2Standard non polar33892256
Dezocine,3TBDMS,isomer #1CC(C)(C)[Si](C)(C)OC1=CC=C2C[C@@H]3CCCCC[C@](C)(C2=C1)[C@H]3N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C2906.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Dezocine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0gbi-0390000000-4fb07f506db70b0c78382017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Dezocine GC-MS (1 TMS) - 70eV, Positivesplash10-022i-3092000000-7f50e64f2ad9db7a8e5c2017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Dezocine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Dezocine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 10V, Positive-QTOFsplash10-002b-0090000000-d9dabb60a74ab655d2182016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 20V, Positive-QTOFsplash10-002b-0190000000-2b145fb3023a36bd24942016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 40V, Positive-QTOFsplash10-0a4l-9870000000-4fc719e20315afc3245f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 10V, Negative-QTOFsplash10-0006-0090000000-a5f27e1a37941ab0555d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 20V, Negative-QTOFsplash10-0006-0090000000-cb7990cb629b70150f272016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 40V, Negative-QTOFsplash10-0gdi-0490000000-eae46a1e3c230f7ed0762016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 10V, Positive-QTOFsplash10-0002-0090000000-d7cdec1563386ebf5cbb2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 20V, Positive-QTOFsplash10-004i-0190000000-95067ae5e2f286647ff02021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 40V, Positive-QTOFsplash10-03g3-4960000000-f756135b9c6d404f0f792021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 10V, Negative-QTOFsplash10-0006-0090000000-b87f9f9b4d097e0a18482021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 20V, Negative-QTOFsplash10-0006-0090000000-b87f9f9b4d097e0a18482021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Dezocine 40V, Negative-QTOFsplash10-052f-0590000000-17256ea206b9a3eae5e92021-10-11Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Membrane
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01209 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB01209 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB01209
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID2297867
KEGG Compound IDC08010
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDezocine
METLIN IDNot Available
PubChem Compound3033053
PDB IDNot Available
ChEBI ID4474
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for beta-endorphin
Gene Name:
OPRM1
Uniprot ID:
P35372
Molecular weight:
44778.9
References
  1. Picker MJ: Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists. J Pharmacol Exp Ther. 1997 Dec;283(3):1009-17. [PubMed:9399970 ]
  2. Barrett AC, Cook CD, Terner JM, Craft RM, Picker MJ: Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids. Psychopharmacology (Berl). 2001 Nov;158(2):154-64. [PubMed:11702089 ]
  3. Cook CD, Barrett AC, Roach EL, Bowman JR, Picker MJ: Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berl). 2000 Jul;150(4):430-42. [PubMed:10958085 ]
  4. Gharagozlou P, Demirci H, David Clark J, Lameh J: Activity of opioid ligands in cells expressing cloned mu opioid receptors. BMC Pharmacol. 2003 Jan 4;3:1. Epub 2003 Jan 4. [PubMed:12513698 ]
  5. Morgan D, Cook CD, Smith MA, Picker MJ: An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity. Anesth Analg. 1999 Feb;88(2):407-13. [PubMed:9972766 ]
  6. Jacobs AM, Youngblood F: Opioid receptor affinity for agonist-antagonist analgesics. J Am Podiatr Med Assoc. 1992 Oct;82(10):520-4. [PubMed:1361946 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Receptor for dynorphins. May play a role in arousal and regulation of autonomic and neuroendocrine functions
Gene Name:
OPRK1
Uniprot ID:
P41145
Molecular weight:
42644.7
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [PubMed:17139284 ]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [PubMed:17016423 ]
  3. Gharagozlou P, Hashemi E, DeLorey TM, Clark JD, Lameh J: Pharmacological profiles of opioid ligands at kappa opioid receptors. BMC Pharmacol. 2006 Jan 25;6:3. [PubMed:16433932 ]
  4. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]